Strategikon Pharma
San Francisco, US · Delaware corporation · 12 known investors
Find your way into Strategikon Pharma
Sign up to see every warm intro you have to Strategikon Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Strategikon Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools. It serves biopharmaceutical companies of all sizes and Clinical Research Organizations (CROs) involved in clinical trial outsourcing.
Founders & leadership


Board


Investors · 12
How we know: av.vc · Not right? Tell us
How we know: Debiopharm Innovation Fund's portfolio page · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · prnewswire.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$2.3M disclosed across 1 of 4 rounds · 2017–2025
- Undisclosed amountSeries AApr 2021
Osage Venture Partners (lead), Band of Angels, Bascom Ventures, Golden Seeds, Life Science Angels, Saratoga Ventures, Inc., Tech Coast Angels, Wing Venture Capital
Source ↗
▶$2.3MraisedNov 2025 · 15 investors · Other TechnologyRule 506(b)
- Rob HessDirector
- Anca CopaescuExecutive Officer, Director
- Debra ApruzzeseDirector
- Chris CodeanneDirector
- Paulo CarvalhoExecutive Officer
- Vincent LepreuxDirector
- Mark WeinsteinExecutive Officer, Director
- Nathanael LentzDirector
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedApr 2018 · Business ServicesRule 506(b)
- Anca CopaescuExecutive Officer, Director, Promoter
- Paulo CarvalhoExecutive Officer, Promoter
- Mark Di IanniExecutive Officer, Director, Promoter
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 04, 06b
▶$1MofferedNov 2017 · Business ServicesRule 506(b)
- Mark Di IanniExecutive Officer, Director, Promoter
- Paulo CarvalhoExecutive Officer, Director, Promoter
- Anca CopaescuExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Minimum investment
- $20K
- Proceeds to insiders
- $150K
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 04, 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Strategikon Pharma do?
- Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools. It serves biopharmaceutical companies of all sizes and Clinical Research Organizations (CROs) involved in clinical trial outsourcing.
- Who founded Strategikon Pharma?
- Strategikon Pharma was founded by Anca Copaescu, Mark Di Ianni.
- Who are Strategikon Pharma's investors?
- Strategikon Pharma's investors include Alumni Ventures, Band of Angels, Debiopharm Innovation Fund, HearstLab, Bascom Ventures, Decathlon Capital Partners, Golden Seeds, Osage Venture Partners and 2 more.
- How much funding has Strategikon Pharma raised?
- Strategikon Pharma has disclosed $2.3M raised across 1 of its 4 known rounds.
- Where is Strategikon Pharma headquartered?
- Strategikon Pharma is headquartered in San Francisco, US.






